Lawal IO, Fourie BP, Mathebula M, et al. - To evaluate the effect of findings on EOT ¹⁸F-FDG PET/CT on tuberculosis relapse in patients treated with a standard regimen of antituberculous treatment (ATT) for drug-sensitive pulmonary tuberculosis (DS-PTB), researchers prospectively included individuals who completed a standard regimen of ATT for DS-PTB and were declared cured based on a negative clinical and bacteriologic examination to undergo EOT ¹⁸F-FDG PET/CT. This study included a total of 53 individuals (mean age, 37.81 ± 11.29 y), with 62% being male and 75% HIV-infected. It was noted that a negative EOT ¹⁸F-FDG PET/CT result is protective against tuberculosis relapse. The study found that nine percent of individuals with RMA after ATT may experience tuberculosis relapse within 6 mo of completing ATT. Among individuals with tuberculosis relapse, bilateral disease with lung cavitation is prevalent.